| Daniel T Matulich, MD | |
|
1165 Montgomery Dr, Santa Rosa Memorial Hospital, Santa Rosa, CA 95405-4801 | |
| (707) 552-1573 | |
| Not Available |
| Full Name | Daniel T Matulich |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1165 Montgomery Dr, Santa Rosa, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043254600 | NPI | - | NPPES |
| 00G486620 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G48662 (California) | Primary |
| Entity Name | Lakeline Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316426505 PECOS PAC ID: 7214281492 Enrollment ID: O20181107002405 |
News Archive
A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer.
Children and adults with autism, a chronic developmental disorder, have difficulty with social and language skills and often display repetitive behaviors, according to background information in the articles.
PURE Bioscience, creator of the patented silver dihydrogen citrate antimicrobial, today announced that its marketing partner, Richmont Sciences, LLC, through its distributor, Bio Care Products Ltd. of Lanseria, has obtained registration of PURE's SDC-based IV-7 Ultimate Germ Defense disinfectant for use on all inanimate surfaces by the South African National Regulator for Compulsory Specifications.
Sanofi-aventis announced today the initiation of a multinational Phase III study evaluating the efficacy and safety of two doses of once daily teriflunomide (7mg or 14mg) versus placebo in patients with relapsing multiple sclerosis (RMS) treated with interferon beta (IFN beta).
› Verified 1 days ago
| Entity Name | Round Rock Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902264963 PECOS PAC ID: 0648524306 Enrollment ID: O20181119001606 |
News Archive
A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer.
Children and adults with autism, a chronic developmental disorder, have difficulty with social and language skills and often display repetitive behaviors, according to background information in the articles.
PURE Bioscience, creator of the patented silver dihydrogen citrate antimicrobial, today announced that its marketing partner, Richmont Sciences, LLC, through its distributor, Bio Care Products Ltd. of Lanseria, has obtained registration of PURE's SDC-based IV-7 Ultimate Germ Defense disinfectant for use on all inanimate surfaces by the South African National Regulator for Compulsory Specifications.
Sanofi-aventis announced today the initiation of a multinational Phase III study evaluating the efficacy and safety of two doses of once daily teriflunomide (7mg or 14mg) versus placebo in patients with relapsing multiple sclerosis (RMS) treated with interferon beta (IFN beta).
› Verified 1 days ago
| Entity Name | Lake Travis Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851803688 PECOS PAC ID: 7315291929 Enrollment ID: O20181120000263 |
News Archive
A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer.
Children and adults with autism, a chronic developmental disorder, have difficulty with social and language skills and often display repetitive behaviors, according to background information in the articles.
PURE Bioscience, creator of the patented silver dihydrogen citrate antimicrobial, today announced that its marketing partner, Richmont Sciences, LLC, through its distributor, Bio Care Products Ltd. of Lanseria, has obtained registration of PURE's SDC-based IV-7 Ultimate Germ Defense disinfectant for use on all inanimate surfaces by the South African National Regulator for Compulsory Specifications.
Sanofi-aventis announced today the initiation of a multinational Phase III study evaluating the efficacy and safety of two doses of once daily teriflunomide (7mg or 14mg) versus placebo in patients with relapsing multiple sclerosis (RMS) treated with interferon beta (IFN beta).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel T Matulich, MD 1165 Montgomery Dr, Santa Rosa, CA 95405-4801 Ph: () - | Daniel T Matulich, MD 1165 Montgomery Dr, Santa Rosa Memorial Hospital, Santa Rosa, CA 95405-4801 Ph: (707) 552-1573 |
News Archive
A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer.
Children and adults with autism, a chronic developmental disorder, have difficulty with social and language skills and often display repetitive behaviors, according to background information in the articles.
PURE Bioscience, creator of the patented silver dihydrogen citrate antimicrobial, today announced that its marketing partner, Richmont Sciences, LLC, through its distributor, Bio Care Products Ltd. of Lanseria, has obtained registration of PURE's SDC-based IV-7 Ultimate Germ Defense disinfectant for use on all inanimate surfaces by the South African National Regulator for Compulsory Specifications.
Sanofi-aventis announced today the initiation of a multinational Phase III study evaluating the efficacy and safety of two doses of once daily teriflunomide (7mg or 14mg) versus placebo in patients with relapsing multiple sclerosis (RMS) treated with interferon beta (IFN beta).
› Verified 1 days ago
Barry Smith, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Santa Rosa Memorial Hospital, 1165 Montgomery Drive, Santa Rosa, CA 95405 Phone: 707-522-1573 | |
Dr. Ridgely Oliver Muller, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1165 Montgomery Dr, Santa Rosa, CA 95405 Phone: 707-525-5207 Fax: 626-397-5643 | |
James John Mc Keith, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1165 Montgomery Dr, Santa Rosa Memorial Hospital, Santa Rosa, CA 95405 Phone: 707-525-5207 | |
Christina Marie Goodwin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1165 Montgomery Dr, M/s 1w04, Santa Rosa, CA 95405 Phone: 707-547-5471 Fax: 707-525-5280 | |
Yizza Narvaez, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-684-1538 | |
S. Mitchell Savitsky, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 |